Aliev B M, Paches A I, Chuprik-Malinovskaia T P
Vopr Onkol. 1990;36(11):1358-61.
The analysis of data on 93 cases of stage III-IV cancer of the oral mucosa showed the superiority of combined treatment over complex in terms of five-year survival: 47 and 20%, respectively (p less than 0.01). However, no significant difference in respect to that parameter was established between the combined treatment group and patients rendered disease-free with complex therapy: 47 and 40%, respectively (p greater than 0.05). In the whole group studied, five-year survival rate was 32 +/- 5%; it was 37 +/- 6 and 25 +/- 7% in patients without and with regional lymph node metastases, respectively.
对93例III - IV期口腔黏膜癌患者的数据分析表明，联合治疗在五年生存率方面优于综合治疗：分别为47%和20%（p小于0.01）。然而，联合治疗组与通过综合治疗实现无病状态的患者在该参数上未发现显著差异：分别为47%和40%（p大于0.05）。在整个研究组中，五年生存率为32±5%；无区域淋巴结转移和有区域淋巴结转移的患者五年生存率分别为37±6%和25±7%。
